After $500M IPO, HK inno.N enters exosome drug delivery
31 May 2022 //
FIERCEPHARMA
ILIAS demonstrated the therapeutic effect of anti-inflammatory exosomes
28 Jun 2021 //
PR NEWSWIRE
ILIAS Biologics the 2nd POC study, showing anti-inflammatory of ILB202
02 Feb 2021 //
PRNASIA
ILIAS announces the 2nd POC study, showing anti-inflammatory effects of ILB202
01 Feb 2021 //
PRNASIA